STREAMEX CORP. (STEX) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$15.16M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$35.75M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$6.11M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$20.36M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -$15.16M | (m) | $146.00K | (m) | (m) | -$11.74M* | (m) | (m) | (m) | -$505.00K |
| 2026-03-31 | Reported | (m) | -$35.75M | (m) | (m) | (m) | (m) | -$10.18M | (m) | (m) | (m) | -$565.00K |
| 2025-09-30 | Reported | (m) | -$6.11M | (m) | (m) | (m) | (m) | -$5.02M* | (m) | $6.00K | (m) | -$765.00K |
| 2025-06-30 | Reported | (m) | -$20.36M | (m) | (m) | (m) | (m) | -$1.28M* | (m) | $19.00K | (m) | (m) |
| 2025-03-31 | Reported | (m) | -$2.98M | (m) | (m) | (m) | (m) | -$1.11M | (m) | $6.00K | (m) | (m) |
| 2024-09-30 | Reported | (m) | -$2.95M | (m) | $0.00* | (m) | (m) | -$1.49M* | (m) | $156.00K | (m) | (m) |
| 2024-06-30 | Reported | -$5.24M* | -$5.29M | $49.00K | $13.00K | -40330.77%* | (m) | -$1.48M* | (m) | $342.00K | (m) | (m) |
| 2024-03-31 | Reported | -$3.36M* | -$3.44M | $78.00K | $14.00K | -23992.86%* | (m) | -$1.31M | (m) | $238.00K | (m) | (m) |
| 2023-09-30 | Reported | -$3.96M* | -$4.05M | $92.00K | $1.00K | -395900.00%* | $60.00K* | -$3.83M* | (m) | $1.15M | (m) | (m) |
| 2023-06-30 | Reported | -$10.82M* | -$10.91M | $92.00K | (m) | (m) | $77.00K* | -$4.89M* | (m) | $1.71M | (m) | $0.00 |
| 2023-03-31 | Reported | -$7.30M* | -$7.39M | $84.00K | (m) | (m) | $45.00K | -$5.65M | (m) | $1.06M | (m) | $0.00 |
| 2022-09-30 | Reported | -$6.40M* | -$6.49M | $84.00K | (m) | (m) | $50.00K* | -$4.95M* | $30.00K | $1.73M | (m) | $0.00 |
| 2022-06-30 | Reported | -$5.64M* | -$5.72M | $71.00K | (m) | (m) | $5.00K* | -$6.70M* | $0.00 | $1.35M | (m) | $0.00 |
| 2022-03-31 | Reported | -$8.01M* | -$8.06M | $55.00K | (m) | (m) | $55.00K | -$5.94M | $0.00 | $1.62M | (m) | $0.00 |
| 2021-09-30 | Reported | -$7.75M* | -$7.80M | $51.00K | (m) | (m) | $216.00K* | -$6.76M* | $38.00K | $1.31M | (m) | $0.00 |
| 2021-06-30 | Reported | -$8.00M* | -$8.05M | $49.00K | (m) | (m) | $52.00K* | -$6.92M* | $62.00K | $1.67M | (m) | $0.00 |
| 2021-03-31 | Reported | -$8.52M* | -$8.56M | $42.00K | (m) | (m) | $130.00K | -$6.99M | $99.00K | $1.27M | (m) | $0.00 |
| 2020-09-30 | Reported | -$13.08M* | -$13.10M | $24.00K | (m) | (m) | $32.00K* | -$6.27M* | (m) | $4.91M | (m) | $0.00 |
| 2020-06-30 | Reported | -$22.33M* | -$22.35M | $22.00K | (m) | (m) | $8.00K* | -$8.28M* | (m) | $5.72M | (m) | $0.00 |
| 2020-03-31 | Reported | -$12.78M* | -$12.80M | $21.00K | (m) | (m) | $20.00K | -$5.94M | (m) | $4.93M | (m) | $0.00 |
| 2019-09-30 | Reported | -$5.48M* | -$5.50M | $18.51K | (m) | (m) | $38.06K* | -$3.94M* | (m) | $1.64M | (m) | $0.00 |
| 2019-06-30 | Reported | -$7.98M* | -$7.99M | $9.98K | (m) | (m) | $30.82K* | -$4.12M* | (m) | $1.82M | (m) | $0.00 |
| 2019-03-31 | Reported | -$5.87M* | -$5.88M | $7.93K | (m) | (m) | $14.42K | -$3.52M | (m) | $1.49M | (m) | $0.00 |
| 2018-09-30 | Reported | -$3.15M* | -$3.15M | $2.98K | (m) | (m) | $13.46K* | -$2.49M* | (m) | $744.17K | (m) | $0.00 |
| 2018-06-30 | Reported | -$5.76M* | -$5.77M | $2.93K | (m) | (m) | $4.57K* | -$2.41M* | (m) | $1.45M | (m) | $0.00 |
| 2018-03-31 | Reported | -$2.63M* | -$2.64M | $2.90K | (m) | (m) | $3.64K | -$2.39M | (m) | $862.42K | (m) | $0.00 |
| 2017-09-30 | Reported | (m) | -$1.91M | (m) | (m) | (m) | $5.17K* | -$1.76M* | (m) | $1.12M | (m) | $0.00 |
| 2017-06-30 | Reported | (m) | -$3.02M | (m) | (m) | (m) | $0.00* | -$1.84M* | (m) | $1.34M | (m) | $0.00 |
| 2017-03-31 | Reported | (m) | -$2.90M | (m) | (m) | (m) | $1.62K | -$1.61M | (m) | $1.34M | (m) | $0.00 |
| 2016-09-30 | Reported | (m) | -$1.55M | (m) | (m) | (m) | $6.54K* | -$1.08M* | (m) | $560.51K | (m) | $0.00 |
| 2016-06-30 | Reported | (m) | -$5.54M | (m) | (m) | (m) | $5.55K* | -$1.60M* | (m) | $1.15M | (m) | $0.00 |
| 2016-03-31 | Reported | (m) | -$2.31M | (m) | (m) | (m) | $0.00 | -$1.17M | (m) | $372.43K | (m) | $0.00 |
| 2015-09-30 | Reported | (m) | -$2.47M | (m) | (m) | (m) | $0.00* | -$862.68K* | (m) | $354.47K | (m) | $0.00 |
| 2015-06-30 | Reported | (m) | -$4.43M | (m) | (m) | (m) | $6.29K* | -$1.35M* | (m) | $489.56K | (m) | $0.00 |
| 2015-03-31 | Reported | (m) | -$3.05M | (m) | (m) | (m) | $2.68K | -$1.22M | (m) | $302.08K | (m) | $0.00 |
| 2014-09-30 | Reported | (m) | -$3.94M | (m) | (m) | (m) | $3.96K* | -$573.47K* | (m) | $144.23K | (m) | $0.00 |
| 2014-06-30 | Reported | (m) | -$588.53K | (m) | (m) | (m) | $0.00* | -$456.62K* | (m) | $99.89K | (m) | $0.00 |
| 2014-03-31 | Reported | (m) | -$728.15K | (m) | (m) | (m) | $0.00 | -$505.76K | (m) | $122.15K | (m) | $0.00 |
| 2013-09-30 | Reported | (m) | -$803.72K | (m) | (m) | (m) | $1.95K* | -$521.85K* | (m) | $289.96K | (m) | $0.00 |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$71.09M | (m) | (m) | (m) | (m) | -$10.44M | (m) | $31.00K | (m) | -$1.25M |
| 2024-12-31 | Reported | (m) | -$12.86M | (m) | $40.00K | (m) | (m) | -$4.76M | (m) | $832.00K | (m) | $0.00 |
| 2023-12-31 | Reported | -$28.15M* | -$28.51M | $361.00K | $18.00K | -156394.44%* | $186.00K | -$17.31M | (m) | $5.09M | (m) | (m) |
| 2022-12-31 | Reported | -$26.97M* | -$27.27M | $293.00K | (m) | (m) | $168.00K | -$21.70M | $57.00K | $5.82M | (m) | $0.00 |
| 2021-12-31 | Reported | -$33.21M* | -$33.41M | $198.00K | (m) | (m) | $542.00K | -$26.40M | $199.00K | $5.60M | (m) | $0.00 |
| 2020-12-31 | Reported | -$59.09M* | -$59.18M | $94.00K | (m) | (m) | $87.00K | -$26.60M | $0.00 | $18.14M | (m) | $0.00 |
| 2019-12-31 | Reported | -$34.55M* | -$34.60M | $54.00K | (m) | (m) | $177.00K | -$15.48M | (m) | $9.74M | (m) | $0.00 |
| 2018-12-31 | Reported | -$17.25M* | -$17.26M | $12.40K | (m) | (m) | $38.03K | -$10.26M | (m) | $4.37M | (m) | $0.00 |
| 2017-12-31 | Reported | (m) | -$12.91M | (m) | (m) | (m) | $9.44K | -$7.47M | (m) | $4.76M | (m) | $0.00 |
| 2016-12-31 | Reported | (m) | -$11.16M | (m) | (m) | (m) | $16.25K | -$5.11M | (m) | $2.65M | (m) | $0.00 |
| 2015-12-31 | Reported | (m) | -$12.04M | (m) | (m) | (m) | $15.86K | -$4.52M | (m) | $1.51M | (m) | $0.00 |
| 2014-12-31 | Reported | (m) | -$7.87M | (m) | (m) | (m) | $3.96K | -$2.00M | (m) | $1.51M | (m) | $0.00 |
| 2013-12-31 | Reported | (m) | -$6.24M | (m) | (m) | (m) | $11.72K | -$1.76M | (m) | $992.21K | (m) | $0.00 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |